{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:37:29Z","timestamp":1783654649125,"version":"3.55.0"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007464","name":"Torsten Soderbergs Stiftelse","doi-asserted-by":"publisher","award":["MT6\/12"],"award-info":[{"award-number":["MT6\/12"]}],"id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003743","name":"Adlerbertska Stiftelserna","doi-asserted-by":"publisher","award":["DE 2011\/36"],"award-info":[{"award-number":["DE 2011\/36"]}],"id":[{"id":"10.13039\/501100003743","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF Foundation at Sahlgrenska","award":["ALF-GBG-126611"],"award-info":[{"award-number":["ALF-GBG-126611"]}]},{"DOI":"10.13039\/501100005689","name":"Gothenburg Medical Society","doi-asserted-by":"publisher","award":["GLS-42311"],"award-info":[{"award-number":["GLS-42311"]}],"id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2009-5000"],"award-info":[{"award-number":["2009-5000"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>We investigated the role of antibodies against the mature portion of glycoprotein G (mgG-2) of herpes simplex virus 2 (HSV-2) in protective immunity after vaccination. Mice were immunized intramuscularly with mgG-2 and oligodeoxynucleotides containing two CpG motifs plus alum as adjuvant. All C57BL\/6 mice survived and presented no genital or systemic disease. High levels of immunoglobulin G subclass 1 (IgG1) and IgG2 antibodies were detected and re-stimulated splenic CD4+ T cells proliferated and produced IFN-\u03b3. None of the sera from immunized mice exhibited neutralization, while all sera exerted antibody-dependent cellular cytotoxicity (ADCC) and complement-mediated cytolysis (ACMC) activity. Passive transfer of anti-mgG-2 monoclonal antibodies, or immune serum, to naive C57BL\/6 mice did not limit disease progression. Immunized B\u2011cell KO mice presented lower survival rate and higher vaginal viral titers, as compared with vaccinated B-cell KO mice after passive transfer of immune serum and vaccinated C57BL\/6 mice. Sera from mice that were vaccinated subcutaneously and intranasally with mgG-2 presented significantly lower titers of IgG antibodies and lower ADCC and ACMC activity. We conclude that anti-mgG-2 antibodies were of importance to limit genital HSV\u20112 infection. ADCC and ACMC activity are potentially important mechanisms in protective immunity, and could tentatively be evaluated in future animal vaccine studies and in clinical trials.<\/jats:p>","DOI":"10.3390\/v6114358","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T11:53:07Z","timestamp":1415793187000},"page":"4358-4372","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-Glycoprotein G Antibodies of Herpes Simplex Virus 2  Contribute to Complete Protection after Vaccination in Mice and Induce Antibody-Dependent Cellular Cytotoxicity and Complement-Mediated Cytolysis"],"prefix":"10.3390","volume":"6","author":[{"given":"Staffan","family":"G\u00f6rander","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Section of Virology, Guldhedsgatan 10 B, S-413 46 Gothenburg, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Box 100, 405 30 G\u00f6teborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ekblad","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Section of Virology, Guldhedsgatan 10 B, S-413 46 Gothenburg, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Box 100, 405 30 G\u00f6teborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Section of Virology, Guldhedsgatan 10 B, S-413 46 Gothenburg, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Box 100, 405 30 G\u00f6teborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-\u00c5ke","family":"Liljeqvist","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Section of Virology, Guldhedsgatan 10 B, S-413 46 Gothenburg, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Box 100, 405 30 G\u00f6teborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"Looker","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.330.6002.304","article-title":"Immunology. Painful failure of promising genital herpes vaccine","volume":"330","author":"Cohen","year":"2010","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials. Chiron HSV vaccine study group","volume":"282","author":"Corey","year":"1999","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/JCM.41.8.3681-3686.2003","article-title":"Secreted portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology","volume":"41","author":"Gorander","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-0934(92)90056-J","article-title":"Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2)","volume":"36","author":"Ho","year":"1992","journal-title":"J. Virol. Methods"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/jcm.22.4.641-644.1985","article-title":"Detection of herpes simplex virus type 2-specific antibody with glycoprotein G","volume":"22","author":"Lee","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/jcm.19.2.235-239.1984","article-title":"Herpes simplex virus type-selective enzyme-linked immunosorbent assay with helix pomatia lectin-purified antigens","volume":"19","author":"Svennerholm","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/jcm.26.4.662-667.1988","article-title":"Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus type 1 and 2 in human sera","volume":"26","author":"Ashley","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1128\/JVI.00186-12","article-title":"Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease","volume":"86","author":"Gorander","year":"2012","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/iai.37.3.1132-1137.1982","article-title":"Protection against lethal challenge of BALB\/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2","volume":"37","author":"Balachandran","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_13","first-page":"5","article-title":"Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection","volume":"41","author":"Bystricka","year":"1997","journal-title":"Acta Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/jiu177","article-title":"Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of glaxosmithkline HSV-2 glycoprotein D2 subunit vaccine","volume":"210","author":"Awasthi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/jvi.38.2.564-570.1981","article-title":"Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein","volume":"38","author":"Olofsson","year":"1981","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1099\/0022-1317-79-5-1215","article-title":"Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies","volume":"79","author":"Liljeqvist","year":"1998","journal-title":"J. Gen. Virol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4049\/jimmunol.123.1.25","article-title":"Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells","volume":"123","author":"Kohl","year":"1979","journal-title":"J. Immunol."},{"key":"ref_20","unstructured":"(2010). Sigma plot 12, Systat Software Inc. 12.0 Build 12.0.0.182."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1128\/JVI.00849-11","article-title":"Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone","volume":"85","author":"Awasthi","year":"2011","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/CVI.05071-11","article-title":"Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models","volume":"18","author":"Khodai","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/jvi.61.4.1125-1135.1987","article-title":"Antigenic cross-reactions among herpes simplex virus types 1 and 2, epstein-barr virus, and cytomegalovirus","volume":"61","author":"Balachandran","year":"1987","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/jvi.55.2.483-488.1985","article-title":"Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions","volume":"55","author":"Para","year":"1985","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jri.2007.08.004","article-title":"Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms","volume":"78","author":"Chu","year":"2008","journal-title":"J. Reprod. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/315208","article-title":"Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine","volume":"181","author":"Kohl","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.iy.09.040191.002325","article-title":"Fc receptors","volume":"9","author":"Ravetch","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/viro.2000.0298","article-title":"Immune protection against HSV-2 in B-cell-deficient mice","volume":"270","author":"Dudley","year":"2000","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2567.2000.00080.x","article-title":"Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice","volume":"101","author":"Parr","year":"2000","journal-title":"Immunology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/JVI.75.3.1195-1204.2001","article-title":"Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells","volume":"75","author":"Morrison","year":"2001","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1128\/JVI.72.11.9208-9216.1998","article-title":"Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT\/muMT mice","volume":"72","author":"Homann","year":"1998","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1099\/0022-1317-83-11-2797","article-title":"Modification of primary and recurrent genital herpes in guinea pigs by passive immunization","volume":"83","author":"Bourne","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1128\/jvi.71.11.8109-8115.1997","article-title":"Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2","volume":"71","author":"Parr","year":"1997","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1099\/0022-1317-74-3-379","article-title":"Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes","volume":"74","author":"Schmidt","year":"1993","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.01924-10","article-title":"Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2011","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e65523","DOI":"10.1371\/journal.pone.0065523","article-title":"Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2","volume":"8","author":"Halford","year":"2013","journal-title":"PLoS One"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1099\/0022-1317-71-7-1497","article-title":"Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2","volume":"71","author":"McDermott","year":"1990","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/infdis\/jit658","article-title":"A paradigm shift: Vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes","volume":"209","author":"Awasthi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/CVI.00230-14","article-title":"Nonneutralizing functional antibodies: A new \u201cold\u201d paradigm for HIV vaccines","volume":"21","author":"Excler","year":"2014","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/6\/11\/4358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:09:14Z","timestamp":1760216954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/6\/11\/4358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"alternative-id":["v6114358"],"URL":"https:\/\/doi.org\/10.3390\/v6114358","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}